AbbVie Inc.


Updates from The Motley Fool

Latest updates on AbbVie from Fool.com.  The Fool has written over 600 articles on AbbVie.
Is AbbVie Inc. (ABBV) a Buy?

The big pharma stock has been a big winner in recent years. But will the future be just as bright?



Stock Performance

View Interactive ABBV Charts
Sponsored by

Key Data Points

Primary metrics and data points about AbbVie.
Current Price: $93.49
Prev Close: $95.55
Open: $96.06
Bid: $93.55
Ask: $93.73
Day's Range: $93.43 - $96.11
52wk Range: $69.38 - $125.86
Volume: 9,744,476
Avg Vol 10,441,790
Market Cap: $149B
P/E (ttm): 24.01
EPS (ttm): $3.98
Div & Yield: $2.84 (4.0%)

Company Rating

What our community thinks about AbbVie.
CAPS Rating 4 out of 5
 
452 Outperform
12 Underperform
CAPS All Stars
 
103 Outperform
2 Underperform

How do you think AbbVie will perform against the market?



You pick for AbbVie is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Richard A. Gonzalez, CEO

89% Approve

Based on 356 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AbbVie.

AbbVie Inc.

  • Exchange: NYSE